Antimicrobial susceptibility of Staphylococcus saprophyticus and urethral staphylococci.

Antimicrobial Agents and Chemotherapy
T J Marrie, C Kwan

Abstract

The activity of eight antimicrobial agents was determined against 115 isolates of Staphylococcus saprophyticus. All were susceptible to ampicillin, cephalexin, and trimethoprim-sulfamethoxazole and resistant to nalidixic acid and novobiocin. A bimodal pattern of susceptibility to erythromycin was observed: 80% were inhibited by 0.25 microgram/ml, whereas 13% required greater than or equal to 128 micrograms/ml. The following urethral staphylococci were susceptible to ampicillin, cephalexin, and nitrofurantoin but resistant to nalidixic acid: S. epidermidis, S. hominis, S. haemolyticus, S. warneri, S. simulans, and S. cohnii.

References

Oct 1, 1979·The British Journal of Venereal Diseases·B HoveliusP A Mårdh
Jan 1, 1975·Journal of Clinical Microbiology·W E Kloos, K H Schleifer
Oct 1, 1978·Journal of Clinical Microbiology·J F JohnN M O'Dell
Apr 1, 1975·Journal of Clinical Pathology·P D MeersG Sandys
Sep 1, 1982·Journal of Clinical Microbiology·T J MarrieL Duffield
Jul 1, 1980·The Journal of Antimicrobial Chemotherapy·J F Richardson, R R Marples
Oct 1, 1980·The Journal of Infectious Diseases·P A JordanH Baer

❮ Previous
Next ❯

Citations

Apr 1, 1985·European Journal of Clinical Microbiology·A F Kent, D C Speller
May 1, 1983·Antimicrobial Agents and Chemotherapy·A M Bourgault, L Gauvreau
Oct 1, 1986·Antimicrobial Agents and Chemotherapy·R J FassL W Ayers
Jun 1, 2011·Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians·Jae-Ik HanKi-Jeong Na
Jun 1, 1984·Mayo Clinic Proceedings·H J SchultzF T Nobrega
Mar 1, 1985·Mayo Clinic Proceedings·J A Washington, W R Wilson
Dec 28, 2010·International Journal of Antimicrobial Agents·Anne Le BouterVincent Cattoir
Dec 20, 2008·Enfermedades infecciosas y microbiología clínica·Beatriz Orden-MartínezRosario Millán-Pérez
Jan 1, 2014·International Scholarly Research Notices·Ravikumar Sreekala SreeragSasidharan Nishanth Kumar
Jun 8, 2017·Frontiers in Microbiology·Maryam Tidjani AlouDidier Raoult
Feb 1, 1984·Journal of Clinical Microbiology·B J Harrington, J M Gaydos

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.